Orchestra BioMed Holdings, Inc. (OBIO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$51.48M
Year ended 2025-12-31
-$57.64M
Trailing 12 months to 2026-06-30
2022-12-31: -$32.44M2023-12-31: -$51.22M2024-12-31: -$63.99M2025-12-31: -$51.48M-$51.48M
2022-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$51.48Mn/m2026-03-12, From 2025-01-01
2024-12-31-$63.99Mn/m2026-03-12, From 2024-01-01
2023-12-31-$51.22Mn/m2025-03-31, From 2023-01-01
2022-12-31-$32.44Mn/a2024-03-27, From 2022-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31-$51.48Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31-$1.95Mn/m
ClearPoint Neuro, Inc. (CLPT)2025-12-31-$23.35Mn/m
Cytosorbents Corp (CTSO)2025-12-31-$13.52Mn/m
Retractable Technologies Inc (RVP)2025-12-31-$13.41Mn/m
Interpace Biosciences, Inc. (IDXG)2025-12-31$4.51M-46.4%
Sensus Healthcare, Inc. (SRTS)2025-12-31-$9.91Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$2.16Mn/m
SS Innovations International, Inc. (SSII)2025-12-31-$7.12Mn/m

Compare OBIO, PREM, CLPT, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗